- Home
- LPCN vs LVTX Comparison
LPCN vs LVTX Comparison
Compare LPCN & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- LVTX
- Stock Information
- Founded
- LPCN 1997
- LVTX 2016
- Country
- LPCN United States
- LVTX Netherlands
- Employees
- LPCN N/A
- LVTX N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- LPCN Health Care
- LVTX Health Care
- Exchange
- LPCN Nasdaq
- LVTX Nasdaq
- Market Cap
- LPCN 36.8M
- LVTX 38.9M
- IPO Year
- LPCN N/A
- LVTX 2021
- Fundamental
- Price
- LPCN $5.16
- LVTX $1.65
- Analyst Decision
- LPCN Strong Buy
- LVTX Strong Buy
- Analyst Count
- LPCN 1
- LVTX 2
- Target Price
- LPCN $10.00
- LVTX $6.00
- AVG Volume (30 Days)
- LPCN 26.5K
- LVTX 51.8K
- Earning Date
- LPCN 11-07-2024
- LVTX 12-03-2024
- Dividend Yield
- LPCN N/A
- LVTX N/A
- EPS Growth
- LPCN N/A
- LVTX N/A
- EPS
- LPCN N/A
- LVTX N/A
- Revenue
- LPCN $7,922,926.00
- LVTX $7,398,000.00
- Revenue This Year
- LPCN N/A
- LVTX N/A
- Revenue Next Year
- LPCN N/A
- LVTX N/A
- P/E Ratio
- LPCN N/A
- LVTX N/A
- Revenue Growth
- LPCN N/A
- LVTX N/A
- 52 Week Low
- LPCN $2.38
- LVTX $1.35
- 52 Week High
- LPCN $11.79
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- LPCN 49.88
- LVTX 46.68
- Support Level
- LPCN $4.64
- LVTX $1.46
- Resistance Level
- LPCN $5.40
- LVTX $1.65
- Average True Range (ATR)
- LPCN 0.51
- LVTX 0.11
- MACD
- LPCN -0.07
- LVTX -0.03
- Stochastic Oscillator
- LPCN 34.48
- LVTX 37.25
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.